CBD is not anticholinergic. Unlike drugs such as diphenhydramine or certain antidepressants that directly block acetylcholine receptors, CBD does not bind to or block muscarinic acetylcholine receptors, which is the primary mechanism behind anticholinergic effects. Its relationship with the cholinergic system is more complex, and in some contexts, CBD may actually support acetylcholine signaling rather than suppress it.
What “Anticholinergic” Actually Means
Anticholinergic drugs work by blocking acetylcholine, a neurotransmitter involved in muscle movement, memory, digestion, and saliva production. When a drug blocks acetylcholine’s receptors, it can cause a recognizable cluster of side effects: dry mouth, constipation, blurred vision, urinary retention, confusion, and drowsiness. Common anticholinergic medications include allergy drugs like diphenhydramine, older antidepressants like amitriptyline, and bladder medications like oxybutynin.
CBD doesn’t fit this category. No published research has found that CBD binds to muscarinic acetylcholine receptors, which are the receptors responsible for the classic anticholinergic side effect profile. Its pharmacology touches the cholinergic system in other ways, but not through the mechanism that defines a drug as anticholinergic.
How CBD Interacts With Nicotinic Receptors
While CBD doesn’t appear to affect muscarinic receptors, it does interact with one type of nicotinic acetylcholine receptor called the alpha-7 receptor. A 2025 study in Cellular and Molecular Life Sciences found that CBD inhibits alpha-7 nicotinic receptor activity at very low concentrations, with an IC50 (the concentration needed to reduce activity by half) of roughly 0.5 micromolar. That’s a potent effect at the cellular level.
However, blocking nicotinic receptors is a different thing from blocking muscarinic receptors. Nicotinic receptors are primarily involved in fast signaling between nerve cells and at nerve-muscle junctions, while muscarinic receptors drive the slower processes behind digestion, heart rate, and glandular secretion. Inhibiting alpha-7 nicotinic receptors doesn’t produce the dry mouth, constipation, or cognitive fog associated with anticholinergic drugs. The clinical significance of CBD’s effect on these receptors is still being studied, but it’s not the same as being anticholinergic in the traditional pharmacological sense.
CBD May Actually Boost Acetylcholine
One of the more surprising findings is that CBD might increase acetylcholine levels rather than suppress them. A 2024 study using a mouse model of Alzheimer’s disease found that long-term CBD inhalation increased acetylcholine expression in the hippocampus, the brain’s memory center. This increase paralleled reduced amyloid plaque buildup and improvements in cognitive function. The researchers described this as the first evidence that CBD’s interaction with the cholinergic system could be beneficial for conditions where acetylcholine is depleted, like Alzheimer’s.
Separately, lab research has shown that CBD competitively inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine after it’s been used. In a 2022 study, CBD inhibited this enzyme by about 71% at a concentration of 200 micromolar. By slowing the breakdown of acetylcholine, CBD could theoretically allow more of it to remain active in the synapse. This is the same basic strategy used by approved Alzheimer’s medications like donepezil, which are considered pro-cholinergic, the opposite of anticholinergic.
These findings are from cell and animal studies, so it’s too early to say how meaningfully CBD boosts acetylcholine in humans at typical supplement doses. But the direction of the effect is noteworthy: CBD appears to preserve acetylcholine rather than block it.
Why CBD Causes Dry Mouth if It’s Not Anticholinergic
Dry mouth is one of CBD’s most commonly reported side effects, which is likely why people wonder about anticholinergic properties. But the mechanism behind CBD-related dry mouth, when it occurs, doesn’t involve blocking acetylcholine receptors.
Research published in Scientific Reports clarified this nicely. In mouse studies, THC reduced saliva production by about half, working through cannabinoid CB1 receptors on the nerve fibers that control the submandibular gland (one of the major saliva-producing glands). These CB1 receptors sit on cholinergic neurons, and when THC activates them, those neurons release less acetylcholine, which in turn reduces saliva output. So THC causes dry mouth by indirectly reducing cholinergic signaling, not by directly blocking acetylcholine receptors.
CBD alone, at the same dose, had no effect on salivation in either male or female mice. Even more interesting, when CBD was given alongside THC, it actually reversed THC’s dry-mouth effect in a dose-dependent way. The researchers attributed this to CBD acting as a negative allosteric modulator of CB1 receptors, essentially interfering with THC’s ability to activate those receptors. If you experience dry mouth from a full-spectrum CBD product, the THC content (even in trace amounts) or other ingredients may be the cause rather than the CBD itself.
CBD Can Amplify Anticholinergic Drug Side Effects
Where CBD does pose a real concern is in drug interactions. CBD is a potent inhibitor of several liver enzymes that metabolize common medications, including CYP2D6, CYP2C19, CYP3A4, and CYP1A2. When CBD slows the breakdown of a drug that already has anticholinergic properties, blood levels of that drug can rise, intensifying its anticholinergic side effects.
Amitriptyline is a well-documented example. This older antidepressant is metabolized by multiple enzymes that CBD inhibits. A comprehensive review in the Journal of General Internal Medicine noted that combining CBD with amitriptyline could increase the risk of anticholinergic syndrome (severe dry mouth, confusion, rapid heartbeat, urinary retention), along with excess drowsiness and heart rhythm changes. The same review flagged that CBD can raise blood levels of antihistamines, another drug class with anticholinergic effects.
So while CBD itself isn’t anticholinergic, it can make anticholinergic drugs behave as though you took a higher dose. If you’re using CBD alongside any medication that causes dry mouth, constipation, or drowsiness, this interaction is worth discussing with a pharmacist.
The Bottom Line on CBD and Acetylcholine
CBD’s relationship with the cholinergic system is real but nuanced. It inhibits one subtype of nicotinic receptor, slows the enzyme that degrades acetylcholine, and in animal models appears to increase acetylcholine levels in the brain. None of these effects qualify it as anticholinergic. If anything, the current evidence leans in the opposite direction, suggesting CBD has mild pro-cholinergic properties. The practical concern isn’t that CBD blocks acetylcholine itself, but that it can boost blood levels of other drugs that do.